To view this email as a web page, click here.

Aesthetic Pearls
 
Stand out
"It's important for dermatologists to not only advertise, but to educate patients on why they should seek a qualified, board certified dermatologist, versus the unqualified injectors who have surfaced on every street corner," says one marketing expert.
Learn more.
ADVERTISEMENT
 
LEO Pharma invests in biotech firm developing aerosol alopecia treatment device
LEO Pharma is investing in biotechnology company Novpyxis, as it develops an aerosol-based drug delivery device used for topical skin treatments, according to a news release.
Learn more.
ADVERTISEMENT
 
In case you missed it
 
Biosimilar familiarity expands
Dermatologists and some psoriasis patients might soon grapple with switching from a biologic to a biosimilar.
Learn more.
 
ADVERTISEMENT
Is your tech saving your practice money?
In the new world of value-based care, technology matters. This whitepaper plugs you into Cloud-based solutions that can help improve clinical outcomes — and transform healthcare IT from a distraction into an advantage. Read the whitepaper now. »
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Atopic dermatitis affects 25% of children & 2-3% of adults
Discover new scientific findings surrounding the pathophysiology of AD and how it is redefining therapeutic management strategies.
Learn more. Earn free CME
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.